Ross Goldstein

Ross Goldstein, MD, MBA, currently serves as Vice President of Medical Affairs at Aura Biosciences, overseeing the medical affairs group across all regions since September 2023. Prior to this role, Goldstein was the Executive Director and Head of Clinical Development and Medical Affairs at Halozyme, Inc., where responsibilities included leading clinical development programs and building a medical affairs organization. Previous experience includes serving as Senior Director of CNS Medical Affairs at Kyowa Kirin, where Goldstein built a team and developed strategies for a new medical franchise, along with roles at Travere Therapeutics, CSL Behring, and Organogenesis, focusing on medical strategy, clinical trials, and key opinion leader engagement. Goldstein completed a residency in General Surgery at Georgetown University Hospital and holds an MD from UMDNJ - Robert Wood Johnson Medical School and an MBA from Rutgers Business School.